Given that IFI30 participates in MHC II‐associated antigen processing, the discovery that its high expression implied poor outcomes for patients with gliomas prompted us to explore the relationship between IFI30 expression and immune cell infiltration by applying the ESTIMATE algorithm.33 The gene discussed is IFI30; the disease is central nervous system cancer.